Sep 15, 2026 07:31AM
Sep 14, 2026 09:26AM
Sep 14, 2026 09:26AM
May 19, 2026 08:01AM
May 14, 2026 07:30AM
Mar 19, 2026 09:25AM
Mar 9, 2026 09:15AM Biofrontera reports positive Phase 2b acne trial results for Ameluz
Mar 9, 2026 09:15AM
Feb 17, 2026 09:15AM
Feb 17, 2026 09:15AM
Feb 11, 2026 09:16AM
Feb 11, 2026 09:15AM
Feb 9, 2026 09:15AM
Feb 9, 2026 09:15AM Biofrontera Announces Positive Results in Phase 3 Study of Ameluz® PDT for Actinic Keratoses on the Extremities, Neck, and Trunk, Meeting Primary Endpoint
Jan 8, 2026 08:46AM
Jan 8, 2026 08:45AM
Dec 18, 2025 08:45AM
Dec 18, 2025 08:45AM
Dec 4, 2025 09:00AM
Dec 4, 2025 09:00AM
Dec 2, 2025 08:45AM Biofrontera files FDA application for skin cancer treatment
Dec 2, 2025 08:45AM
Nov 13, 2025 08:15AM
Nov 7, 2025 08:00AM
Nov 7, 2025 08:00AM
Sep 16, 2025 10:30AM
Sep 16, 2025 10:30AM
Sep 16, 2025 10:30AM Biofrontera Inc. Announces Last Patient Out in Phase 3 Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% Photodynamic Therapy (PDT) for the Treatment of Actinic Keratoses (AK) on the Extrem
Aug 25, 2025 08:27AM
Aug 25, 2025 08:25AM
Aug 11, 2025 04:25PM
Aug 11, 2025 04:25PM
Jun 30, 2025 08:00AM
Jun 3, 2025 02:30PM
Jun 3, 2025 02:30PM Biofrontera Inc. Announces Patent for Propylene Glycol-Free Formula of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% Now Listed in FDA Orange Book
May 15, 2025 12:17PM
May 15, 2025 12:17PM
Mar 21, 2025 08:00AM
Mar 18, 2025 09:30AM
Jan 8, 2025 09:51AM
Jan 8, 2025 09:50AM
Dec 23, 2024 09:31AM Biofrontera Inc. (BFRI) Announces 100 RhodoLED XL Machines Now Placed in US Market
Dec 23, 2024 09:30AM
Nov 13, 2024 05:15PM
Oct 31, 2024 10:33AM
Oct 31, 2024 10:32AM
Oct 14, 2024 10:30AM
Oct 14, 2024 10:30AM
Oct 7, 2024 02:04PM Roth/MKM Reiterates Buy Rating on Biofrontera (BFRI)
Oct 7, 2024 08:45AM

331,678 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All